- Home
- TRSG vs IBIO Comparison
TRSG vs IBIO Comparison
Compare TRSG & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRSG
- IBIO
- Stock Information
- Founded
- TRSG 1996
- IBIO 2008
- Country
- TRSG Singapore
- IBIO United States
- Employees
- TRSG N/A
- IBIO N/A
- Industry
- TRSG
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- TRSG
- IBIO Health Care
- Exchange
- TRSG NYSE
- IBIO Nasdaq
- Market Cap
- TRSG 25.8M
- IBIO 24.3M
- IPO Year
- TRSG 2024
- IBIO N/A
- Fundamental
- Price
- TRSG $1.51
- IBIO $0.76
- Analyst Decision
- TRSG
- IBIO Strong Buy
- Analyst Count
- TRSG 0
- IBIO 3
- Target Price
- TRSG N/A
- IBIO $4.87
- AVG Volume (30 Days)
- TRSG 46.6K
- IBIO 1.2M
- Earning Date
- TRSG 12-31-2024
- IBIO 05-12-2025
- Dividend Yield
- TRSG N/A
- IBIO N/A
- EPS Growth
- TRSG N/A
- IBIO N/A
- EPS
- TRSG N/A
- IBIO N/A
- Revenue
- TRSG $14,441,864.00
- IBIO $375,000.00
- Revenue This Year
- TRSG N/A
- IBIO $36.00
- Revenue Next Year
- TRSG N/A
- IBIO $33.33
- P/E Ratio
- TRSG N/A
- IBIO N/A
- Revenue Growth
- TRSG 9.34
- IBIO 650.00
- 52 Week Low
- TRSG $1.00
- IBIO $0.87
- 52 Week High
- TRSG $11.78
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- TRSG N/A
- IBIO 19.10
- Support Level
- TRSG N/A
- IBIO $0.64
- Resistance Level
- TRSG N/A
- IBIO $1.00
- Average True Range (ATR)
- TRSG 0.00
- IBIO 0.32
- MACD
- TRSG 0.00
- IBIO -0.10
- Stochastic Oscillator
- TRSG 0.00
- IBIO 3.55
About TRSG TUNGRAY TECHNOLOGIES INC
Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.